27 April 2022 - Minneapolis, United States - Imricor Medical Systems, Inc. ( Company or Imricor )( ASX:IMR ), the global leader in realtime iCMR cardiac ablation products, today releases its Appendix 4C Quarterly Cash Flow Report for the period ending 31 March 2022 and provides an update on its operational performance.
